These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37131085)

  • 21. Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.
    Hartmann F; Sparla D; Tute E; Tamm M; Schneider U; Jeon MK; Kasperk R; Gassler N; Kaemmerer E
    Pathol Res Pract; 2017 Mar; 213(3):261-266. PubMed ID: 28153554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.
    Zhang H; Gu H; Li L; Ren Y; Zhang L
    Tumour Biol; 2016 May; 37(5):5919-23. PubMed ID: 26592252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Catenin and AKT are promising targets for combination therapy in acute myeloid leukemia.
    Wang L; You LS; Ni WM; Ma QL; Tong Y; Mao LP; Qian JJ; Jin J
    Leuk Res; 2013 Oct; 37(10):1329-40. PubMed ID: 23867056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.
    Mashek DG; McKenzie MA; Van Horn CG; Coleman RA
    J Biol Chem; 2006 Jan; 281(2):945-50. PubMed ID: 16263710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
    Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
    Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway.
    Xi HM; Lu H; Weng XQ; Sheng Y; Wu J; Li L; Cai X
    Anticancer Agents Med Chem; 2023; 23(9):1074-1084. PubMed ID: 36627782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
    Mei S; Zhang Y; Yu L; Chen G; Zi F
    Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.
    Fiskus W; Sharma S; Saha S; Shah B; Devaraj SG; Sun B; Horrigan S; Leveque C; Zu Y; Iyer S; Bhalla KN
    Leukemia; 2015 Jun; 29(6):1267-78. PubMed ID: 25482131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
    Gassler N; Roth W; Funke B; Schneider A; Herzog F; Tischendorf JJ; Grund K; Penzel R; Bravo IG; Mariadason J; Ehemann V; Sykora J; Haas TL; Walczak H; Ganten T; Zentgraf H; Erb P; Alonso A; Autschbach F; Schirmacher P; Knüchel R; Kopitz J
    Gastroenterology; 2007 Aug; 133(2):587-98. PubMed ID: 17681178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propofol inhibits biological functions of leukaemia stem and differentiated cells through suppressing Wnt/β-catenin and Akt/mTOR.
    Chen L; Wan Y; Liu Y; Li T
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):127-134. PubMed ID: 31429973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt/β-catenin axis.
    Lu Y; Zhong L; Luo X; Liu C; Dan W; Chu X; Wan P; Zhang Z; Wang X; Liu Z; Liu B
    Mol Cell Probes; 2022 Jun; 63():101805. PubMed ID: 35259424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting Axin2 and modulating the Wnt/β-catenin pathway.
    Liu Z; Zhong L; Dan W; Chu X; Liu C; Luo X; Zhang Z; Lu Y; Wan P; Wang X; Liu B
    Biochem Biophys Res Commun; 2022 Sep; 620():83-91. PubMed ID: 35780585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.
    Beghini A; Corlazzoli F; Del Giacco L; Re M; Lazzaroni F; Brioschi M; Valentini G; Ferrazzi F; Ghilardi A; Righi M; Turrini M; Mignardi M; Cesana C; Bronte V; Nilsson M; Morra E; Cairoli R
    Neoplasia; 2012 Dec; 14(12):1236-48. PubMed ID: 23308055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DACT3 has a tumor-inhibiting role in acute myeloid leukemia via the suppression of Wnt/β-catenin signaling by DVL2.
    Gao Q; Hou L; Wang H; Xun L
    J Biochem Mol Toxicol; 2022 May; 36(5):e23014. PubMed ID: 35187752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological targeting of type phosphodiesterase 4 inhibits the development of acute myeloid leukemia by impairing mitochondrial function through the Wnt/β-catenin pathway.
    Mao P; Huang C; Li Y; Zhao Y; Zhou S; Zhao Z; Mu Y; Wang L; Li F; Zhao AZ
    Biomed Pharmacother; 2023 Jan; 157():114027. PubMed ID: 36436494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives.
    Wagstaff M; Coke B; Hodgkiss GR; Morgan RG
    Biosci Rep; 2022 Apr; 42(4):. PubMed ID: 35352805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
    Liu Y; Wang W; Li Y; Huang Y
    Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
    Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
    Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.